Katia Bruxvoort
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 24
- COVID-19 Clinical Research Studies 17
- Health top 2%
- Vaccine Coverage and Hesitancy 25
- Modeling and Simulation top 2%
- Epidemiology top 5%
- Pneumonia and Respiratory Infections 10
- Urinary Tract Infections Management 9
- Respiratory viral infections research 8
- Influenza Virus Research Studies 7
- Microbiology top 5%
-
- Malaria Research and Control 11
Katia Bruxvoort
96 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Infectious Diseases 766
- Health 328
- Modeling and Simulation 121
- Epidemiology 491
- Microbiology 75
Countries citing papers authored by Katia Bruxvoort
This map shows the geographic impact of Katia Bruxvoort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katia Bruxvoort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katia Bruxvoort more than expected).
Fields of papers citing papers by Katia Bruxvoort
This network shows the impact of papers produced by Katia Bruxvoort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katia Bruxvoort. The network helps show where Katia Bruxvoort may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Katia Bruxvoort, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 47 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 2 | |
| 14 | 2022 | 11 | |
| 15 | 2021 | 31 | |
| 16 | 2021 | 30 | |
| 17 | 2019 | 18 | |
| 18 | The Nature of Competition faced by Private Providers of Maternal Health Services in Uttar Pradesh, India | 2017 | 3 |
| 19 | 2007 | 78 | |
| 20 | 2007 | 135 |
About Katia Bruxvoort
Katia Bruxvoort is a scholar working on Health, Infectious Diseases and Family Practice, having authored 106 papers that have together received 1.9k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (25 papers), SARS-CoV-2 and COVID-19 Research (24 papers), COVID-19 Clinical Research Studies (17 papers), Malaria Research and Control (11 papers), Pneumonia and Respiratory Infections (10 papers), Urinary Tract Infections Management (9 papers), Respiratory viral infections research (8 papers) and Influenza Virus Research Studies (7 papers). The work is most often cited by research in Infectious Diseases (766 citations), Health (328 citations) and Modeling and Simulation (121 citations). Katia Bruxvoort has collaborated with scholars based in United States, United Kingdom and Tanzania. Frequent co-authors include Bradley K. Ackerson, Hung Fu Tseng, Lina S. Sy, Lei Qian, Yi Luo, Catherine Goodman, Yun Tian, Ana Florea, Carla Talarico and S. Patrick Kachur. Their work appears in journals such as Proceedings of the National Academy of Sciences, JAMA and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.